表紙
市場調查報告書
商品編碼
995179

一氧化氮吸入療法的全球市場:各應用 (新生兒呼吸系主導療、慢性阻塞性肺病 (COPD)、急性呼吸窘迫症候群 (ARDS))、地區的產業分析與預測 (2020∼2026年)

Global Inhaled Nitric Oxide Market By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications), By Region, Industry Analysis and Forecast, 2020 - 2026

出版日期: | 出版商: KBV Research | 英文 123 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球一氧化氮吸入療法市場規模,預計至2026年達到9億1570萬美元,在預測期間中以7%的年複合成長率擴大。

新生兒的低氧性呼吸不全(HRF)和持續性肺高血壓等嬰兒疾病的盛行率上升,是市場主要推動要素之一。再加上慢性阻塞性肺病(COPD)及急性呼吸窘迫症候群(ARDS)的患者數增加,也推動市場成長。另一方面,氣體的各種用途相關治療嚴格的政府政策伴隨的莫大費用,限制一氧化氮吸入治療市場成長。可是,為了發現醫療保健部門的各種新應用的無間隙的研究開發活動,估計提供擴大在預測期間內全球一氧化氮吸入治療市場的有益機會。

本報告提供全球一氧化氮吸入療法市場相關調查,市場概要,競爭分析,各市場區隔、各地區的分析與預測,並提供主要企業簡介等資訊。

目錄

第1章 市場範圍&調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 一氧化氮吸入療法市場上展開策略

第4章 全球一氧化氮吸入療法市場:各應用領域

  • 全球新生兒呼吸系主導療市場:各地區
  • 全球慢性阻塞性肺病(COPD)市場:各地區
  • 全球急性呼吸窘迫症候群(ARDS)市場:各地區
  • 全球及其他的應用市場:各地區

第5章 全球一氧化氮吸入療法市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • LAMEA

第6章 企業簡介

  • Getinge AB
  • Merck Group
  • Halma PLC
  • Linde PLC (Praxair, Inc.)
  • Air Liquide S.A.
  • Beyond Air, Inc.
  • Mallinckrodt PLC (International Minerals and Chemical Corporation)
  • VERO Biotech LLC
  • Nu-Med Plus, Inc.
  • Novoteris, LLC
目錄

The Global Inhaled Nitric Oxide Market size is expected to reach $915.7 Million by 2026, rising at a market growth of 7% CAGR during the forecast period. Nitric oxide is a molecule of gas that causes a sense of relaxation in smooth muscle cells in the vasculature. It is because Nitric Oxide reacts with oxyhemoglobin. The gas is quickly collected by oxyhemoglobin in red blood cells and the vasodilating effects caused by inhaled nitric oxide are restricted to oxygenated areas of the lungs. Thus, this distinct ability of Nitric oxide to cause pulmonary vasodilatation in the oxygenated regions of the lung helps in enhancing oxygenation of the blood and reduces intrapulmonary right to left shunting. Hence, the inhaled nitric oxide is utilized to cure various cardiopulmonary conditions, like pulmonary hypertension in adults and children. Although, the usage of inhaled nitric oxide is restricted due to logistical and financial reasons.

The rising prevalence of diseases in infants like a neonatal hypoxic respiratory failure (HRF) and persistent pulmonary hypertension is among the key driving factors of the market. Moreover, the growing number of patients with chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) also propel the market growth. Apart from this, the huge cost involved in the treatment & the stringent government policies on different applications of the gas are restricting the growth of Inhaled Nitric Oxide market. However, the constant R&D activities for discovering various new applications in the healthcare sector are estimated to offer profitable opportunities for expanding the global inhaled nitric oxide market during the forecast period.

The declaration of WHO about the Covid-19 outbreak as a public health emergency has affected every country around the globe. During the pandemic, nitric oxide got under several experiments to test whether it can help in treating Covid-19 affected people, due to its antiviral properties and enhanced oxygenation. Inhaled Nitric Oxide is useful in safeguarding the frontline healthcare workers from this pandemic.

Application Outlook

Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Neonatal respiratory treatment segment procured the substantial revenue share and is estimated to exhibit high growth rate during the forecast period. This is due a surge in the occurrences of diseases in the newborn like persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF). The chronic obstructive pulmonary disease segment would display promising growth rate during the forecast period.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as the leading region in the global inhaled nitric oxide market in 2019. The high growth of the regional market is due to the large consumer base & rising funding in R&D by the leading players. Major determinants such as surge in rates of chronic diseases in the newborn like persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF) are expected to support the market growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.

Strategies deployed in Inhaled Nitric Oxide Market

Dec-2020: Beyond Air introduced a pilot clinical trial analyzing its investigational therapy LungFit GO. It is an inhaled nitric oxide, which can be self-administrated at home, in adults with or without cystic fibrosis (CF) those who have chronic, treatment-resistant lung infections caused by non-tuberculosis mycobacteria (NTM).

Nov-2020: Mallinckrodt announced the beginning of a retrospective chart review study, under the title "Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)" to accumulate real-world data on the usage of INOmax (nitric oxide) gas, for inhalation therapy in patients with respiratory complications related to the novel coronavirus SARS-CoV-2 (COVID-19).

Nov-2020: Beyond Air submitted its premarket approval (PMA) application for its LungFit PH to the U.S. Food and Drug Administration (FDA). LungFit PH helps in curing persistent pulmonary hypertension of the newborn (PPHN). FDA guidelines permitted for a 180-day review period for a PMA. LungFit PH produces nitric oxide from ambient air and transmits it to a ventilator making it a safer and more convenient environment for patients and medical staff.

Oct-2020: Beyond Air announced the beginning of a clinical study of the LungFit system. This system is used for assessment of the safety and efficacy of high concentration inhaled NO given at particular intervals to the hospitalized adults with acute viral pneumonia, including SARS-CoV-2.

May-2020: Mallinckrodt joined hands with Massachusetts General Hospital. In this collaboration, the companies aimed to analyze the potential advantages of inhaled nitric oxide as a treatment for pulmonary complications in COVID-19 patients. The collaboration also evaluate the benefits of INOmax (nitric oxide) gas in mechanically ventilated patients who have serious Acute Respiratory Syndrome caused by COVID-19.

Apr-2020: Mallinckrodt and Novoteris got approval by Health Canada for initiating a pilot study of an inhaled formulation of nitric oxide (NO) as a possible treatment for coronavirus. This study was carried out at Vancouver Coastal Health Authority facilities. It has tested a high-concentration form of NO called Thiolanox in development by the companies, delivered by utilizing a specialized Novoteris delivery device.

Apr-2020: Beyond Air got a clean chit by the U.S. Food and Drug Administration (FDA) for initiating a clinical study in the U.S. using the LungFit TM system to cure COVID-19 patients. Applications for funding were incomplete with the Biomedical Advance Research and Development Authority (BARDA), a division of Health and Human Services (HHS).

Mar-2020: Beyond Air received an approval from Health Canada to use LungFit system for study in hospitalized patients infected with COVID-19 caused by the serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Dec-2019: VERO Biotech received an approval of GENOSYL (nitric oxide) gas, for inhalation by the US Food and Drug Administration (FDA). GENOSYL is contraindicated in the process of treating the neonates dependent on right-to-left shunting of blood.

Jun-2017: Novoteris announced that the US Food and Drug Administration and the Therapeutic Products Directorate of Health Canada have given them a clean chit on its Phase 2 clinical trial application. The company has further initiated recruiting subjects into its Phase 2 trial that used inhaled nitric oxide for the treatment of Cystic Fibrosis (CF).

Feb-2017: Nu-Med Plus signed a stock agreement with Smith Corporate Services, a professional project management and contact center management consulting firm. The agreement enabled company to continue to move forward by redefining the INO arena and move further on the path to fill for regulatory approval of their products which included their proprietary conversion technology.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Neonatal Respiratory Treatment
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Respiratory Distress Syndrome (ARDS)
  • Other Applications

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Australia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Getinge AB
  • Merck Group
  • Halma PLC
  • Linde PLC (Praxair, Inc.)
  • Air Liquide S.A.
  • Beyond Air, Inc.
  • Mallinckrodt PLC (International Minerals and Chemical Corporation)
  • VERO Biotech LLC
  • Nu-Med Plus, Inc.
  • Novoteris, LLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Inhaled Nitric Oxide Market, by Application
    • 1.4.2 Global Inhaled Nitric Oxide Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market composition
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market

Chapter 4. Global Inhaled Nitric Oxide Market by Application

  • 4.1 Global Neonatal Respiratory Treatment Repellent Market by Region
  • 4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region
  • 4.3 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region
  • 4.4 Global Other Applications Market by Region

Chapter 5. Global Inhaled Nitric Oxide Market by Region

  • 5.1 North America Inhaled Nitric Oxide Market
    • 5.1.1 North America Inhaled Nitric Oxide Market by Application
      • 5.1.1.1 North America Neonatal Respiratory Treatment Repellent Market by Country
      • 5.1.1.2 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
      • 5.1.1.3 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country
      • 5.1.1.4 North America Other Applications Market by Country
    • 5.1.2 North America Inhaled Nitric Oxide Market by Country
      • 5.1.2.1 USA Inhaled Nitric Oxide Market
        • 5.1.2.1.1 USA Inhaled Nitric Oxide Market by Application
      • 5.1.2.2 Canada Inhaled Nitric Oxide Market
        • 5.1.2.2.1 Canada Inhaled Nitric Oxide Market by Application
      • 5.1.2.3 Mexico Inhaled Nitric Oxide Market
        • 5.1.2.3.1 Mexico Inhaled Nitric Oxide Market by Application
      • 5.1.2.4 Rest of North America Inhaled Nitric Oxide Market
        • 5.1.2.4.1 Rest of North America Inhaled Nitric Oxide Market by Application
  • 5.2 Europe Inhaled Nitric Oxide Market
    • 5.2.1 Europe Inhaled Nitric Oxide Market by Application
      • 5.2.1.1 Europe Neonatal Respiratory Treatment Repellent Market by Country
      • 5.2.1.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
      • 5.2.1.3 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country
      • 5.2.1.4 Europe Other Applications Market by Country
    • 5.2.2 Europe Inhaled Nitric Oxide Market by Country
      • 5.2.2.1 Germany Inhaled Nitric Oxide Market
        • 5.2.2.1.1 Germany Inhaled Nitric Oxide Market by Application
      • 5.2.2.2 UK Inhaled Nitric Oxide Market
        • 5.2.2.2.1 UK Inhaled Nitric Oxide Market by Application
      • 5.2.2.3 France Inhaled Nitric Oxide Market
        • 5.2.2.3.1 France Inhaled Nitric Oxide Market by Application
      • 5.2.2.4 Russia Inhaled Nitric Oxide Market
        • 5.2.2.4.1 Russia Inhaled Nitric Oxide Market by Application
      • 5.2.2.5 Spain Inhaled Nitric Oxide Market
        • 5.2.2.5.1 Spain Inhaled Nitric Oxide Market by Application
      • 5.2.2.6 Italy Inhaled Nitric Oxide Market
        • 5.2.2.6.1 Italy Inhaled Nitric Oxide Market by Application
      • 5.2.2.7 Rest of Europe Inhaled Nitric Oxide Market
        • 5.2.2.7.1 Rest of Europe Inhaled Nitric Oxide Market by Application
  • 5.3 Asia Pacific Inhaled Nitric Oxide Market
    • 5.3.1 Asia Pacific Inhaled Nitric Oxide Market by Application
      • 5.3.1.1 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country
      • 5.3.1.2 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
      • 5.3.1.3 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country
      • 5.3.1.4 Asia Pacific Other Applications Market by Country
    • 5.3.2 Asia Pacific Inhaled Nitric Oxide Market by Country
      • 5.3.2.1 China Inhaled Nitric Oxide Market
        • 5.3.2.1.1 China Inhaled Nitric Oxide Market by Application
      • 5.3.2.2 India Inhaled Nitric Oxide Market
        • 5.3.2.2.1 India Inhaled Nitric Oxide Market by Application
      • 5.3.2.3 Japan Inhaled Nitric Oxide Market
        • 5.3.2.3.1 Japan Inhaled Nitric Oxide Market by Application
      • 5.3.2.4 South Korea Inhaled Nitric Oxide Market
        • 5.3.2.4.1 South Korea Inhaled Nitric Oxide Market by Application
      • 5.3.2.5 Singapore Inhaled Nitric Oxide Market
        • 5.3.2.5.1 Singapore Inhaled Nitric Oxide Market by Application
      • 5.3.2.6 Australia Inhaled Nitric Oxide Market
        • 5.3.2.6.1 Australia Inhaled Nitric Oxide Market by Application
      • 5.3.2.7 Rest of Asia Pacific Inhaled Nitric Oxide Market
        • 5.3.2.7.1 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application
  • 5.4 LAMEA Inhaled Nitric Oxide Market
    • 5.4.1 LAMEA Inhaled Nitric Oxide Market by Application
      • 5.4.1.1 LAMEA Neonatal Respiratory Treatment Repellent Market by Country
      • 5.4.1.2 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
      • 5.4.1.3 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country
      • 5.4.1.4 LAMEA Other Applications Market by Country
    • 5.4.2 LAMEA Inhaled Nitric Oxide Market by Country
      • 5.4.2.1 Brazil Inhaled Nitric Oxide Market
        • 5.4.2.1.1 Brazil Inhaled Nitric Oxide Market by Application
      • 5.4.2.2 Argentina Inhaled Nitric Oxide Market
        • 5.4.2.2.1 Argentina Inhaled Nitric Oxide Market by Application
      • 5.4.2.3 UAE Inhaled Nitric Oxide Market
        • 5.4.2.3.1 UAE Inhaled Nitric Oxide Market by Application
      • 5.4.2.4 Saudi Arabia Inhaled Nitric Oxide Market
        • 5.4.2.4.1 Saudi Arabia Inhaled Nitric Oxide Market by Application
      • 5.4.2.5 South Africa Inhaled Nitric Oxide Market
        • 5.4.2.5.1 South Africa Inhaled Nitric Oxide Market by Application
      • 5.4.2.6 Nigeria Inhaled Nitric Oxide Market
        • 5.4.2.6.1 Nigeria Inhaled Nitric Oxide Market by Application
      • 5.4.2.7 Rest of LAMEA Inhaled Nitric Oxide Market
        • 5.4.2.7.1 Rest of LAMEA Inhaled Nitric Oxide Market by Application

Chapter 6. Company Profiles

  • 6.1 Getinge AB
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 Merck Group
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Halma PLC
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
  • 6.4 Linde PLC (Praxair, Inc.)
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional Analysis
    • 6.4.4 Research & Development Expense
    • 6.4.5 Recent strategies and developments:
      • 6.4.5.1 Acquisition and Mergers:
  • 6.5 Air Liquide S.A.
    • 6.5.1 Company Overview
    • 6.5.1 Financial Analysis
  • 6.6 Beyond Air, Inc.
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Research & Development Expense
    • 6.6.4 Recent strategies and developments:
      • 6.6.4.1 Trials and Approvals:
  • 6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Segmental and Regional Analysis
    • 6.7.4 Research & Development Expense
    • 6.7.5 Recent strategies and developments:
      • 6.7.5.1 Trials and Approvals:
      • 6.7.5.2 Partnerships, Collaborations, and Agreements:
  • 6.8 VERO Biotech LLC
    • 6.8.1 Company Overview
    • 6.8.2 Recent strategies and developments:
      • 6.8.2.1 Trials and Approvals:
  • 6.9 Nu-Med Plus, Inc.
    • 6.9.1 Company Overview
    • 6.9.2 Recent strategies and developments:
      • 6.9.2.1 Partnerships, Collaborations, and Agreements:
  • 6.10. Novoteris, LLC
    • 6.10.1 Company Overview
    • 6.10.2 Recent strategies and developments:
      • 6.10.2.1 Trials and Approvals:

LIST OF TABLES

  • TABLE 1 Global Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 2 Global Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 3 Global Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 4 Global Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 5 Global Neonatal Respiratory Treatment Repellent Market by Region, 2016 - 2019, USD Million
  • TABLE 6 Global Neonatal Respiratory Treatment Repellent Market by Region, 2020 - 2026, USD Million
  • TABLE 7 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region, 2016 - 2019, USD Million
  • TABLE 8 Global Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Region, 2020 - 2026, USD Million
  • TABLE 9 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region, 2016 - 2019, USD Million
  • TABLE 10 Global Acute Respiratory Distress Syndrome (ARDS) Market by Region, 2020 - 2026, USD Million
  • TABLE 11 Global Other Applications Market by Region, 2016 - 2019, USD Million
  • TABLE 12 Global Other Applications Market by Region, 2020 - 2026, USD Million
  • TABLE 13 Global Inhaled Nitric Oxide Market by Region, 2016 - 2019, USD Million
  • TABLE 14 Global Inhaled Nitric Oxide Market by Region, 2020 - 2026, USD Million
  • TABLE 15 North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 16 North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 17 North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 18 North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 19 North America Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 20 North America Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 21 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 22 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 23 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
  • TABLE 24 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
  • TABLE 25 North America Other Applications Market by Country, 2016 - 2019, USD Million
  • TABLE 26 North America Other Applications Market by Country, 2020 - 2026, USD Million
  • TABLE 27 North America Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
  • TABLE 28 North America Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
  • TABLE 29 USA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 30 USA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 31 USA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 32 USA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 33 Canada Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 34 Canada Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 35 Canada Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 36 Canada Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 37 Mexico Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 38 Mexico Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 39 Mexico Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 40 Mexico Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 41 Rest of North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 42 Rest of North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 43 Rest of North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 44 Rest of North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 45 Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 46 Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 47 Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 48 Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 49 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 50 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 51 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 52 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 53 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
  • TABLE 54 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
  • TABLE 55 Europe Other Applications Market by Country, 2016 - 2019, USD Million
  • TABLE 56 Europe Other Applications Market by Country, 2020 - 2026, USD Million
  • TABLE 57 Europe Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
  • TABLE 58 Europe Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
  • TABLE 59 Germany Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 60 Germany Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 61 Germany Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 62 Germany Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 63 UK Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 64 UK Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 65 UK Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 66 UK Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 67 France Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 68 France Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 69 France Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 70 France Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 71 Russia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 72 Russia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 73 Russia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 74 Russia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 75 Spain Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 76 Spain Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 77 Spain Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 78 Spain Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 79 Italy Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 80 Italy Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 81 Italy Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 82 Italy Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 83 Rest of Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 84 Rest of Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 85 Rest of Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 86 Rest of Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 87 Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 88 Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 89 Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 90 Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 91 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 92 Asia Pacific Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 93 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 94 Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 95 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
  • TABLE 96 Asia Pacific Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
  • TABLE 97 Asia Pacific Other Applications Market by Country, 2016 - 2019, USD Million
  • TABLE 98 Asia Pacific Other Applications Market by Country, 2020 - 2026, USD Million
  • TABLE 99 Asia Pacific Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
  • TABLE 100 Asia Pacific Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
  • TABLE 101 China Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 102 China Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 103 China Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 104 China Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 105 India Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 106 India Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 107 India Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 108 India Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 109 Japan Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 110 Japan Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 111 Japan Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 112 Japan Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 113 South Korea Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 114 South Korea Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 115 South Korea Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 116 South Korea Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 117 Singapore Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 118 Singapore Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 119 Singapore Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 120 Singapore Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 121 Australia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 122 Australia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 123 Australia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 124 Australia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 125 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 126 Rest of Asia Pacific Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 127 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 128 Rest of Asia Pacific Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 129 LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 130 LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 131 LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 132 LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 133 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 134 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 135 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
  • TABLE 136 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
  • TABLE 137 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
  • TABLE 138 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
  • TABLE 139 LAMEA Other Applications Market by Country, 2016 - 2019, USD Million
  • TABLE 140 LAMEA Other Applications Market by Country, 2020 - 2026, USD Million
  • TABLE 141 LAMEA Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
  • TABLE 142 LAMEA Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
  • TABLE 143 Brazil Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 144 Brazil Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 145 Brazil Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 146 Brazil Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 147 Argentina Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 148 Argentina Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 149 Argentina Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 150 Argentina Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 151 UAE Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 152 UAE Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 153 UAE Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 154 UAE Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 155 Saudi Arabia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 156 Saudi Arabia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 157 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 158 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 159 South Africa Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 160 South Africa Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 161 South Africa Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 162 South Africa Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 163 Nigeria Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 164 Nigeria Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 165 Nigeria Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 166 Nigeria Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 167 Rest of LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
  • TABLE 168 Rest of LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
  • TABLE 169 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
  • TABLE 170 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
  • TABLE 171 Key Information - Getinge AB
  • TABLE 172 key Information - Merck Group
  • TABLE 173 key Information - Halma PLC
  • TABLE 174 key Information - Linde PLC
  • TABLE 175 Key information - Air Liquide S.A.
  • TABLE 176 Key information - Beyond Air, Inc.
  • TABLE 177 Key information - Mallinckrodt PLC
  • TABLE 178 Key Information - VERO Biotech LLC
  • TABLE 179 key Information - Nu-Med Plus, Inc.
  • TABLE 180 key Information -Novoteris, LLC

List of Figures

  • FIG 1 Methodology for the research